Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2016 (2016), Article ID 4049373, 17 pages
http://dx.doi.org/10.1155/2016/4049373
Research Article

PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal Villi

Departamento de Ciencias Fisiológicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Distrito Capital, Colombia

Received 15 December 2015; Revised 8 April 2016; Accepted 12 May 2016

Academic Editor: Adriana Ribeiro Silva

Copyright © 2016 Dory Gómez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Children: reducing mortality,” Fact Sheet No 178, World Health Organization, Geneva, Switzerland, 2009, http://www.who.int/mediacentre/factsheets/fs178/en/index.htm. View at Google Scholar
  2. M. Estes and A. Kapikian, “Rotaviruses,” in Fields Virology, D. M. Knipe, P. M. Howley, D. E. Griffin et al., Eds., pp. 1917–1974, Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  3. C. A. Guerrero, P. Pardo, V. Rodriguez, R. R. Guerrero, and O. Acosta, “Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors,” Memórias do Instituto Oswaldo Cruz, vol. 108, no. 6, pp. 741–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. A. Rossen, J. Bouma, R. H. C. Raatgeep, H. A. Büller, and A. W. C. Einerhand, “Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step,” Journal of Virology, vol. 78, no. 18, pp. 9721–9730, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Guerrero, D. P. Torres, L. L. García, R. A. Guerrero, and O. Acosta, “N-acetylcysteine treatment of rotavirus-associated diarrhea in children,” Pharmacotherapy, vol. 34, no. 11, pp. e333–e340, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Guerrero, A. Murillo, and O. Acosta, “Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARγ agonists and NSAIDs,” Antiviral Research, vol. 96, no. 1, pp. 1–12, 2012. View at Publisher · View at Google Scholar
  7. R. Clark, “The role of PPARs in inflammation and immunity,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 388–400, 2002. View at Google Scholar
  8. D. S. Straus and C. K. Glass, “Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms,” Trends in Immunology, vol. 28, no. 12, pp. 551–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. Jarrar and A. Baranova, “PPARγ activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFβ signalling,” Journal of Cellular and Molecular Medicine, vol. 11, no. 1, pp. 71–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Qi, Y. Zhu, and J. K. Reddy, “Peroxisome proliferator-activated receptors, coactivators, and downstream targets,” Cell Biochemistry and Biophysics, vol. 32, pp. 187–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Hong and P. Tontonoz, “Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors,” Current Opinion in Genetics and Development, vol. 18, no. 5, pp. 461–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. R. Skolnik, M. F. Rabbi, J.-M. Mathys, and A. S. Greenberg, “Stimulation of peroxisome proliferator-activated receptors α and γ blocks HIV-1 replication and TNFα production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects,” Journal of Acquired Immune Deficiency Syndromes, vol. 31, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Arnold, M. Neumann, and W. König, “Peroxisome proliferator-activated receptor-γ agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells,” Immunology, vol. 121, no. 1, pp. 71–81, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Wakui, J. Inoue, Y. Ueno et al., “Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-γ ligand, rosiglitazone,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 508–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Oeckinghaus and S. Ghosh, “The NF-kappaB family of transcription factors and its regulation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4, article a000034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. W. Lim, H. Kim, and K. H. Kim, “Nuclear factor-κB regulates cyclooxyoenase-2 expression and cell proliferation in human gastric cancer cells,” Laboratory Investigation, vol. 81, no. 3, pp. 349–360, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Babji and G. Kang, “Rotavirus vaccination in developing countries,” Current Opinion in Virology, vol. 2, no. 4, pp. 443–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Holloway and B. S. Coulson, “Innate cellular responses to rotavirus infection,” Journal of General Virology, vol. 94, no. 6, pp. 1151–1160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. W. Graff, K. Ettayebi, and M. E. Hardy, “Rotavirus NSP1 inhibits NFκB activation by inducing proteasome-dependent degradation of β-TrCP: a novel mechanism of IFN antagonism,” PLoS Pathogens, vol. 5, no. 1, Article ID e1000280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. J. Candace, Country National Immunization Program (NIP). Introductions of Rotavirus Vaccine, PATH, 2014.
  21. J. L. Schwartz, “Rotavirus vaccines, intussusception, and risk-benefit assessments,” JAMA Pediatrics, vol. 167, no. 12, pp. 1093–1094, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. Anderson, “Rotavirus vaccines: viral shedding and risk of transmission,” The Lancet Infectious Diseases, vol. 8, no. 10, pp. 642–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. A. Lopman, V. E. Pitzer, R. Sarkar et al., “Understanding reduced rotavirus vaccine efficacy in low socio-economic settings,” PLoS ONE, vol. 7, no. 8, article e41720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Patel, V. R. López-Collada, M. M. Bulhões et al., “Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil,” The New England Journal of Medicine, vol. 364, no. 24, pp. 2283–2292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Guerrero, A. Y. Santana, and O. Acosta, “Mouse intestinal villi as a model system for studies of rotavirus infection,” Journal of Virological Methods, vol. 168, no. 1-2, pp. 22–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. C. P. Sodhi, R. Katyal, S. V. Rana, S. Attri, and V. Singh, “Study of oxidative-stress in rotavirus infected infant mice,” Indian Journal of Medical Research, vol. 104, pp. 245–249, 1996. View at Google Scholar · View at Scopus
  27. J. Marill, N. Idres, C. C. Capron, E. Nguyen, and G. G. Chabot, “Retinoic acid metabolism and mechanism of action: a review,” Current Drug Metabolism, vol. 4, no. 1, pp. 1–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Draper, C. M. Reynolds, M. Canavan, K. H. Mills, C. E. Loscher, and H. M. Roche, “Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ,” Journal of Nutritional Biochemistry, vol. 22, no. 8, pp. 784–790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-I. Oka, H. Kamata, K. Kamata, H. Yagisawa, and H. Hirata, “N-Acetylcysteine suppresses TNF-induced NF-κB activation through inhibition of IκB kinases,” FEBS Letters, vol. 472, no. 2-3, pp. 196–202, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. R. E. Randall and S. Goodbourn, “Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures,” Journal of General Virology, vol. 89, no. 1, pp. 1–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. M. Arnold, A. Sen, H. B. Greenberg, and J. T. Patton, “The battle between rotavirus and its host for control of the interferon signaling pathway,” PLoS Pathogens, vol. 9, no. 1, Article ID e1003064, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Dutta, T. Sen, A. Banerji, S. Das, and A. Chatterjee, “Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7),” Journal of Oncology, vol. 2009, Article ID 627840, 13 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Dai, K. Yamasaki, Y. Shirakata, K. Sayama, and K. Hashimoto, “All-trans-retinoic acid induces interleukin-8 via the nuclear factor-κB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes,” Journal of Investigative Dermatology, vol. 123, no. 6, pp. 1078–1085, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. L. Reshi, Y.-C. Su, and J.-R. Hong, “RNA viruses: ROS-mediated cell death,” International Journal of Cell Biology, vol. 2014, Article ID 467452, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Buccigrossi, G. Laudiero, C. Russo et al., “Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes,” PLoS ONE, vol. 9, no. 6, Article ID e99830, 2014. View at Publisher · View at Google Scholar · View at Scopus